News

Fierce Pharma35m
BMS shrugs off Cobenfy's schizophrenia hit as it gears up for Alzheimer's psychosis readout, 7 trial starts
On the heels of a clinical setback for Bristol Myers Squibb’s schizophrenia newcomer Cobenfy, the New Jersey pharma is ...
Fierce Pharma39m
Merck ‘willing to work’ with Trump administration on price gap between US, international medicines
With potential tariffs and other drug pricing policies on the horizon, the industry is navigating uncertain waters. | The ...